Skip to content

The Effectiveness and Cost-effectiveness of Doin (Conduction Exercise) for Chronic Neck Pain

CompletedNot applicableNCT03558178
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

A multi-center randomized controlled trial assessing the comparative effectiveness and cost-effectiveness of Doin (conduction exercise) with acupuncture for chronic neck pain

Study details

Official title
The Effectiveness and Cost-effectiveness of Doin (Conduction Exercise) for Chronic Neck Pain: A Multi-center Randomized Controlled Trial
Interventions
Sponsor
Jaseng Medical Foundation
Collaborators
Kyung Hee University Hospital at Gangdong
Start date
2018-07-06
Primary completion
2019-01-08
Sex
All
Age range
from 19 Years to 70 Years
Results posted
No results posted in this snapshot
Countries
South Korea
Total sites listed
5

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Neck area pain duration of 6 months or longer * Current Numeric Rating Scale (NRS) for neck area pain of 5 or higher * Patients who have agreed to voluntarily participate in the clinical trial and given written informed consent Exclusion Criteria: * Patients diagnosed with serious pathology(s) which may cause neck pain (e.g. malignant tumor, spinal infection, inflammatory spondylitis) * Progressive neurologic deficit or severe neurologic symptoms (e.g. cauda equina syndrome, progressive muscle weakness) * Pathologies of non-spinal or soft tissue origin or high severity which may cause neck or radiating arm pain (e.g. malignant tumor, spinal infection, inflammatory spondylitis, fibromyalgia, rheumatic arthritis, gout) * Other chronic diseases which may interfere with treatment effect or interpretation of results (e.g. cardiovascular disorder, renal disease, diabetic neuropathy, dementia, epilepsy) * Current intake of steroids, immunosuppressant medicine, psychiatric medicine or other medication which may interfere with treatment results * Patients considered unsuitable or unsafe to receive acupuncture (e.g. patients with hemorrhagic diseases, blood clotting disorders, history of anti-coagulation medicine intake, severe diabetes with high risk of infection, severe cardiovascular diseases) * Patients who were treated with invasive interventions such as acupuncture or injections, or with medicine that may potentially influence pain such as NSAIDs (nonsteroidal antiinflammatory drugs) within the past week * History of cervical surgery within the past 3 months * Pregnancy or plans of pregnancy * Severe psychopathy * Participation in other clinical studies * Inability to give written informed consent * Other reasons rendering trial participation inappropriate as judged by the researchers

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03558178